Drug profile · INN
enoxaparin sodium
CLEXANE FORTE SAFETY-LOCK
enoxaparin sodium (CLEXANE FORTE SAFETY-LOCK) is a antithrombin-iii activator. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — enoxaparin sodium
- US status
- approved
- Class
- Blood and blood forming organs (B01)
- Route
- INJECTION
- Patents
- 4
- Programs
- 25
- Data quality
- 0.89
Quick answer
enoxaparin sodium (CLEXANE FORTE SAFETY-LOCK) is a antithrombin-iii activator. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Antithrombin-III activator
Primary target: Antithrombin-III
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12258418
Claudin18.2 binding moieties and uses thereof
granted -
US 11608489
Compositions and methods for performing magnetibuoyant separations
granted -
US 11168146
Compositions and methods for increasing protein half-life in a serum
granted -
US 10407508
Compositions and methods for increasing protein half-life in a serum
granted
Frequently asked questions
What is enoxaparin sodium?
enoxaparin sodium (CLEXANE FORTE SAFETY-LOCK) is a antithrombin-iii activator. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for enoxaparin sodium?
CLEXANE FORTE SAFETY-LOCK is a marketed brand name for enoxaparin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of enoxaparin sodium?
enoxaparin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.